, a member of the INK4 family of cyclindependent kinase inhibitors, negatively regulates the proto-oncogenic cyclin D/CDK4(6) complexes whose ability to phosphorylate the retinoblastoma tumour suppressor (RB) promotes G1/S transition. In contrast to the related p16
Introduction
The incidence of testicular germ-cell cancer, the most common malignancy in young men, has recently shown an alarming rise in the industrialized countries. This trend, together with the worrying decline in male reproductive health, and the fascinating biology of the germ cells and germ-cell tumours (GCTs), have stimulated increased eorts to better understand the cellular and molecular biology of reproduction, and the molecular pathogenesis of testicular cancer (Andrews, 1998; Dieckmann and Skakkebñk, 1999; Grigor and Wylie, 1998; Skakkebñk et al., 1987) . One of the unifying concepts emerging from these eorts is the notion that defects in the cell cycle machinery may signi®cantly contribute to oncogenesis in the human testis. Analogous to other types of malignancies, the cell-cycle regulatory pathway deregulated in most testicular GCTs appears to be the G1 phase-controlling mechanism centered around the retinoblastoma tumour suppressor protein (pRB), commonly referred to as thè RB pathway' (Bartek et al., 1996; Hall and Peters, 1996; Sherr, 1996) . The core of this mechanism consists of pRB and its immediate upstream regulators, the Dtype cyclins (D1, D2, and D3), their partner kinases Cdk4 and Cdk6, and the four members of the INK4 family of Cdk inhibitors: p16 INK4a , p15 INK4b , p18
INK4c
, and p19
INK4d (Bartek et al., 1996; Hall and Peters, 1996; Sherr, 1996) . pRB controls commitment of mammalian somatic cells to initiate DNA synthesis, at least in part by repressing activity of the E2F transcription factors required for expression of a range of S phase genes (Bernards, 1997; Helin, 1998) . Upon mitogenic stimulation, pRB's growth suppressive activity is neutralized in G1 through phosphorylation by cyclin D/Cdk4(6) kinases, a process negatively regulated by the INK4 inhibitors. In diverse types of cancer, the RB pathway becomes deregulated through alterations in one or more of its components, the most common defects being loss or mutation of the p16
INK4a or pRB tumour suppressors, or overexpression of the proto-oncogenic cyclin D1 (Hall and Peters, 1996; Sherr, 1996; Bartek et al., 1997; Ruas and Peters, 1998) .
Regulation of cell proliferation in testis and testicular cancer dier from other tissues, mainly due to the specialized reproductive function re¯ected by the presence in seminiferous tubules of two types of cell cycles, mitotic and meiotic, and by the pluripotency of the germ-cell tumours including teratomas capable of dierentiating along various cellular lineages (Andrews, 1998; Mosto® et al., 1986; Oosterhuis and Looijenga, 1993) . The unique biology of the testis may also underlie the emerging spectrum of`unorthodox' tumour-associated alterations in the RB pathway so far identi®ed in human testicular cancer. Thus, cyclin D2 rather than cyclin D1 is frequently overexpressed in the common precursor lesion of all germ-cell tumours, carcinoma in situ (CIS), and this aberration is preserved in the invasive testicular tumours including seminomas and embryonal carcinomas, and in cell lines derived from such tumours (Bartkova et al., 1999; Houldsworth et al., 1997; Sicinski et al., 1996) . In addition, while expression of pRB is aberrantly low in many germ-cell tumours, this appears to be due to a reversible transcriptional modulation, rather than deletions or mutations of the RB gene seen in other types of cancer (Strohmeyer et al., 1991) . Genetic analyses of clinical specimens also revealed subsets of primary testicular germ-cell tumours with mutations or promoter methylation of p16
INK4a (Chaubert et al., 1997; Heidenreich et al., 1998) , whose candidacy for a tumour suppressor has so far been supported mainly by studies of mouse models (Franklin et al., 1998; Ruas and Peters, 1998; Roussel, 1999) , correlates with progression of human testicular tumours from the carcinoma in situ stage to invasive lesions .
In this study, we examined normal human testis and testicular germ-cell tumours for abundance and expression patterns of p19
INK4d (Chan et al., 1995; Guan et al., 1996; Hirai et al., 1995) , the only INK4 family member so far directly implicated in testicular function through work on gene knock-out mice (Zindy et al., 2000) . The fact that a marked testicular atrophy was the only obvious phenotype of mice de®cient in p19
INK4d (Zindy et al., 2000) , in contrast to apparently normal testes in mice genetically deprived of the INK4a locus (Serrano et al., 1996) , suggested a speci®c role of p19
INK4d in mouse spermatogenesis. Marked testicular defects in mice devoid of Cdk4 (Rane et al., 1999) or cyclin D2 (Sicinski et al., 1996) further suggested a critical role of cyclin D-dependent kinases and their regulators in testis biology. While searching for potential aberrations of p19
INK4d
in testicular tumours, we were also hoping to address the puzzling discrepancy between the apparently indistinguishable biochemical properties of all INK4 family members including the p16
INK4a tumour suppressor and the fact that p19
INK4d appears to be neither deleted nor mutated in tumours (Ruas and Peters, 1998).
Results and Discussion
To assess the abundance and localization of the p19
INK4d protein in normal human testicular tissue active in spermatogenesis, a series of specimens from normal adult testis (n=8) and samples of morphologically normal tissue adjacent to testicular tumours (n=21) were examined by immunohistochemistry using a mouse monoclonal antibody DCS-100 speci®c for p19
INK4d . The immunostaining signal was restricted to seminiferous tubules, with maximum intensity in spermatocytes, and much weaker or no staining in spermatogonia and spermatids ( Figure 1 ). No other cell types present in normal testis showed any detectable staining, including Leydig cells and stromal elements outside the tubules, or Sertoli cells inside the tubules (Figure 1 ). The p19
INK4d protein localized mainly to cell nuclei (Figure 1a ), but variable signal was also detectable in the cytoplasm. These results were con®rmed by parallel staining with a rabbit antiserum against p19
INK4d (M-167; Santa Cruz Biotechnology), except for a somewhat increased background staining with this polyclonal antibody (data not shown). Negative controls, including nonimmune mouse serum or the monoclonal antibody DCS-100 pre-absorbed with puri®ed, recombinant p19
INK4d exhibited no detectable staining. The mouse monoclonal antibody DCS-118 speci®c for p18 INK4c Bartkova et al., 2000) , used here as a positive control, showed a considerably wider spectrum of positively stained cell types in normal testis (data not shown, and Bartkova et al., 2000) . Since this is the ®rst immunohistochemical study of the p19
INK4d protein in any species, comparison with related data from other laboratories is limited to recent reports on immunoblotting detection of the p19
INK4d protein in mouse testicular tissue lysates (Zindy et al., 1997) , and analysis of p19
INK4d mRNA in mouse adult testis by Zindy et al. (2000) whose in situ hybridization data are consistent with our present ®nding of the p19 INK4d in a normal seminiferous tubule with the monoclonal antibody DCS-100 . Arrowheads mark the edge of the tubule, S indicates stroma, and C marks the tubule center. Note the strong positivity of spermatocytes, in contrast to weak staining of spermatogonia and spermatids (magni®cation6320). The insert shows two spermatocytes at higher magni®cation, to better illustrate the nuclear localization of p19. (b) Schematic representation of the cell types from the periphery to the centre of the seminiferous tubule, based on detailed analysis of over 500 seminiferous tubules. The p19 protein staining intensity is indicated on the left (dotted line=negative, broken line=weak, and the thick continuous line=strong staining; the curved arrow indicates the mitotic activity of proliferating spermatogonia)
One concept of male germ-cell tumorigenesis, supported by clinico-pathological evidence, suggests that the carcinoma in situ (CIS) of the testis, the likely common precursor of all types of testicular germ-cell tumours, may be derived from the primordial germ cells that have been delayed in their progression to spermatogonia (Rajpert-De Meyts et al., 1998; Skakkebñk et al., 1987) . This concept has prompted a new classi®cation of germ-cell tumours which is based on biological understanding of the histogenesis, and which proposes a term`gonocytoma' for seminomatous tumours and`gonocytoma in situ' for CIS (Grigor, 1993; Grigor and Wyllie, 1998) . A major argument in favour of the above hypothesis comes from comparative analyses of foetal germ cells which share a number of morphological and biochemical features with CIS cells (Jùrgensen et al., 1995; Rajpert-De Meyts et al., 1998; Dieckmann and Skakkebñk, 1999) . Given the evidence for high abundance of the p19
INK4d protein during human spermatogenesis (this study), and the structural and biochemical similarities of p19
INK4d with the p16
INK4a tumour suppressor (Ruas and Roussel, 1999) , we wished to explore the potential role, if any, of p19 INK4d in human testicular germ-cell pathogenesis. As the ®rst step, an immunohistochemical analysis of six prenatal testis specimens (obtained from abortions or upon deaths due to premature birth) from human foetuses between 15 weeks of gestation and birth was performed using either single-antibody staining with DCS-100 against p19
INK4d
, or double staining with DCS-100 and an antibody against placental alkaline phosphatase (PIAP). The latter antibody was chosen based on its established value as a marker of a signi®cant subset of human foetal germ cells, and the characteristic localization of this enzyme in the cytoplasm at the cell periphery (Hustin et al., 1987; Jùrgensen et al., 1995) , thereby allowing any potential nuclear staining for p19
INK4d to be detected in such cells. No p19
INK4d protein was detected with either method, and examples of results obtained with either the double-staining approach (showing a cytoplasmic ring of PIAP positivity with antibody NCL-PLAP-8A9 from Novocastra Laboratories in a subset of foetal germ cells yet no detectable nuclear staining with the DCS-100 antibody) or the single-antibody staining for p19
INK4d are shown in Figure 2a and b, respectively. These results show that in contrast to its high abundance in normal adult seminiferous tubules, the p19
INK4d protein is very low or absent during the prenatal and perinatal phases of human testis development.
Analogous to foetal testes, examination of CIS specimens (n=20) revealed the lack of any detectable p19
INK4d protein in all cases (Figure 2c ). Immunohistochemical analysis of a series of invasive germ-cell tumours, including seminomas, embryonal carcinomas and teratomas showed almost complete absence of the p19
INK4d protein, with the exception of several cases which displayed a low percentage of tumour cells with moderate positivity (Table 1 , and Figure 2d ± f) . A characteristic pattern distinct from the majority of the germ-cell tumours was observed in two teratomas with dierentiated adenomatous structures which contained a subset of epithelial elements strongly positive for p19
INK4d (Figure 2f , and Table 1 ). This pattern was reminiscent of some normal human glandular epithelia (J Bartkova, unpublished results) and most likely re¯ects the ability of the pluripotent teratomas to mimick dierentiation along diverse lineages. In Figure 2 Immunoperoxidase staining for p19
INK4d in human foetal testis and testicular germ-cell tumours. (a) Double staining for PlAP (Jùrgensen et al., 1995) and p19 INK4d (antibody DCS-100, Thullberg et al., 2000) in human foetal testis at 13 weeks of gestation. Note the membrane/cytoplasmic signal of PlAP in a subset of embryonal germ cells, and the lack of any nuclear staining indicating absence of p19. (b) Single staining of human foetal testis with antibody to p19
INK4d con®rms the lack of p19. (c) Staining for p19 is negative in carcinoma in situ (cis), in contrast to strong positivity of spermatocytes in the adjacent normal seminiferous tubule (arrowheads). , and two spermatocytomas one of which showed a minor subset of cells with high abundance of the p19
INK4d protein (Table 1) . Overall, the immunohistochemical data indicated a clear dierence between the abundant p19
INK4d in the spermatocytic lineage in normal adult testis, compared with virtually no or only rare expression of this CDK inhibitor in testicular tumours (Table 1) . To verify these data and to exclude any cross-reactions or epitope masking phenomena as potential explanations of our ®ndings, we examined whole-tissue extracts from three normal adult testis specimens and a subset of CIS and invasive germ-cell tumours by immunoblotting. The antibody DCS-100, previously shown to speci®cally recognize only the p19
INK4d member of the INK4 family, without any cross-reactions with other cellular proteins present in whole-cell lysates of human cell lines , detected only a 19 kDa band on blots prepared from electrophoretically separated proteins extracted from normal adult testis (Figure 3a, lane 1) . In contrast, only very weak, if any such band was detected in blots of analogous protein extracts prepared from pure carcinoma in situ of the testis (Figure 3b, lane 2) . The immunoblotting analysis excluded any major cross-reaction of the DCS-100 antibody in normal human adult testis, and con®rmed the very low-to-undetectable levels of p19
INK4d in CIS. The immunoblotting results obtained with other specimens (see Figure 3b for additional examples) were also consistent with the conclusions deduced from the immunostaining patterns, thereby con®rming the clear distinction between the strong expression of p19
INK4d in normal spermatocytes, versus lack of it in fetal germ cells and in lesions representing diverse tumour types and stages of testicular cancer development.
The present results may be conceptually signi®cant from at least two points of view. First, the distinct and highly reproducible expression patterns of p19
INK4d in testicular tissues and tumours are consistent with the theory of origin of the human male germ-cell tumours from the primordial germ cells (Grigor and Wylie, 1998; Dieckmann and Skakkebñk, 1999; Skakkebñk et al., 1987) . Second, our data shed new light on the puzzling issue of redundancy within the INK4 family of Cdk inhibitors (Ruas and Peters, 1998; Sherr and Roberts, 1999) , in particular the question why p19
INK4d which shares its biochemical properties with the closely related p16 INK4a tumour suppressor, is apparently not targeted by mutations in cancer. Thus, while both Cdk4 (Rane et al., 1999) , the major target of all INK4 family members (Sherr and Roberts, 1999) , and p19
INK4d (Zindy et al., 2000) appear essential for proper development and function of the testis, the lack of the p19
INK4d gene in the mouse does not result in an increased incidence of testicular tumours (Zindy et al., 2000) . Taken together with our present data, we propose that the answer to this puzzle may lie in a tight regulation of expression of p19 One case was negative, the other showed rather strong staining in 3 ± 5% of the cells Figure 3 Immunoblotting analysis of p19
INK4d in tissue extracts from normal human testis and testicular germ-cell tumours. (a) High expression of p19 in normal adult testis tissue (lane 1) versus very low-to-undetectable p19 in carcinoma in situ (lane 2). Wholetissue extracts were prepared from a series of frozen sections, and analysed by denaturing polyacrylamide gel electrophoresis and immunoblotting (antibody DCS-100) as reported (Bartkova et al., 1998) switched on at a precise stage of normal spermatogen
